PubRank

S T Shulman

Author PubWeight™ 149.34‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA 1997 5.24
2 Diagnosis and management of infective endocarditis and its complications. Circulation 1999 4.77
3 Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. JAMA 1995 4.18
4 Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr 1991 2.82
5 Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA 1990 2.61
6 Prevention of Bacterial Endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Disease in the Young. Circulation 1984 2.33
7 Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation 1997 2.32
8 Diagnosis and therapy of Kawasaki disease in children. Circulation 1993 2.32
9 Group C beta-hemolytic streptococcal infections in children: nine pediatric cases and review. Rev Infect Dis 1989 2.09
10 Seven-year national survey of Kawasaki disease and acute rheumatic fever. Pediatr Infect Dis J 1994 1.99
11 Abandoning empirical antibiotics for febrile children. Lancet 1997 1.75
12 Kawasaki disease in infants less than one year of age. J Pediatr 1995 1.67
13 Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr 1997 1.64
14 CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis 2001 1.62
15 Potential mechanisms for failure to eradicate group A streptococci from the pharynx. Pediatrics 1999 1.61
16 Optical immunoassay test for group A beta-hemolytic streptococcal pharyngitis. An office-based, multicenter investigation. JAMA 1997 1.61
17 Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. J Pediatr 1991 1.60
18 IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease. J Infect Dis 2000 1.58
19 Clinical aspects of acute rheumatic fever. J Rheumatol Suppl 1991 1.57
20 Kawasaki syndrome. Rev Infect Dis 1988 1.55
21 Kawasaki syndrome. Pediatr Clin North Am 1999 1.53
22 Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 1994 1.52
23 Prevention of giant coronary artery aneurysms in Kawasaki disease by intravenous gamma globulin therapy. J Pediatr 1988 1.49
24 Evaluation of an ELISA for group A streptococcal antigen for diagnosis of pharyngitis. J Pediatr 1987 1.47
25 Incomplete Kawasaki disease with coronary artery involvement. J Pediatr 1987 1.46
26 IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. J Immunol 1997 1.44
27 The unusual severity of Mycoplasmal pneumonia in children with sickle-cell disease. N Engl J Med 1972 1.35
28 Prevention of rheumatic fever. A statement for health professionals by the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Circulation 1988 1.34
29 Fatal hepatitis B in early infancy: the importance of identifying HBsAg-positive pregnant women and providing immunoprophylaxis to their newborns. Pediatrics 1983 1.33
30 Kawasaki syndrome. Clin Microbiol Rev 1998 1.28
31 Does Kawasaki disease have a retroviral aetiology? Lancet 1986 1.26
32 Ewingella americana: recurrent pseudobacteremia from a persistent environmental reservoir. J Clin Microbiol 1987 1.25
33 Lymphadenitis as the dominant manifestation of Kawasaki disease. Pediatrics 1994 1.23
34 Penicillin plus rifampin eradicates pharyngeal carriage of group A streptococci. J Pediatr 1985 1.21
35 Neurocysticercosis among children in Chicago. Clin Infect Dis 1996 1.21
36 Risk factors associated with candidemia in the neonatal intensive care unit: a case-control study. Pediatr Infect Dis J 1987 1.19
37 Nosocomial infection rates in US children's hospitals' neonatal and pediatric intensive care units. Am J Infect Control 2001 1.18
38 Primary amoebic meningoencephalitis: a report of two cases and antibiotic and immunologic studies. J Infect Dis 1981 1.16
39 Oligoclonal IgA response in the vascular wall in acute Kawasaki disease. J Immunol 2001 1.16
40 Kawasaki disease in older children and adolescents. J Pediatr 2000 1.15
41 Cardiac transplantation for Kawasaki disease. Pediatrics 1997 1.13
42 Periorbital and orbital cellulitis in children. Pediatrics 1978 1.13
43 Correlation of antibiotic synergy in vitro and in vivo: use of an animal model of neutropenic gram-negative sepsis. J Infect Dis 1986 1.12
44 Risk of coronary abnormalities due to Kawasaki disease in urban area with small Asian population. Am J Dis Child 1987 1.09
45 An unique presentation of sickle cell disease: pyogenic hepatic abscess. Pediatrics 1971 1.08
46 Staphylococcus lugdunensis: an emerging cause of ventriculoperitoneal shunt infections. Pediatr Neurosurg 2001 1.06
47 Prevention of bacterial endocarditis: recommendations by the American Heart Association. Clin Infect Dis 1997 1.06
48 A nosocomial common source outbreak caused by Pseudomonas pickettii. Pediatr Infect Dis 1984 1.04
49 Transection of spinal cord. A rare obstetrical complication of cephalic delivery. Arch Dis Child 1971 1.04
50 Angiogenesis in fatal acute Kawasaki disease coronary artery and myocardium. Pediatr Cardiol 2005 1.03
51 The absence of evidence of staphylococcal toxin involvement in the pathogenesis of Kawasaki disease. J Infect Dis 1995 1.01
52 Kawasaki disease. Am Fam Physician 1999 0.99
53 Search for highly conserved viral and bacterial nucleic acid sequences corresponding to an etiologic agent of Kawasaki disease. Pediatr Res 1994 0.99
54 Differences in antibody response to streptococcal antigens in children with rheumatic and non-rheumatic mitral valve disease. Circulation 1974 0.99
55 The search for the etiology of Kawasaki disease. Pediatr Infect Dis J 1987 0.98
56 Clindamycin treatment of chronic pharyngeal carriage of group A streptococci. J Pediatr 1991 0.98
57 Single-dose ceftriaxone pharmacokinetics in pediatric patients with central nervous system infections. J Pediatr 1983 0.97
58 Streptococcal pharyngitis: the carrier state, definition, and management. Pediatr Ann 1998 0.97
59 Pulmonary and cerebral mycetoma caused by Curvularia pallescens. J Pediatr 1977 0.96
60 Multiple group B streptococcal infections in a premature infant: eradication of nasal colonization with rifampin. Am J Dis Child 1985 0.96
61 Serum amyloid A and high density lipoprotein participate in the acute phase response of Kawasaki disease. Pediatr Res 1997 0.95
62 Recent developments in Kawasaki disease. Curr Opin Infect Dis 2001 0.94
63 Lung abscess in infants and children. Clin Pediatr (Phila) 1995 0.93
64 Large outbreak of pertussis among young children in Chicago, 1993: investigation of potential contributing factors and estimation of vaccine effectiveness. Pediatr Infect Dis J 1996 0.93
65 Tuberculosis-associated hemophagocytic syndrome in an infant. Pediatr Infect Dis J 2000 0.93
66 Risk factors for pertussis in young infants during an outbreak in Chicago in 1993. Clin Infect Dis 1996 0.93
67 Peripheral gangrene associated with Kawasaki disease. Clin Infect Dis 1992 0.91
68 Once daily ceftriaxone for central nervous system infections and other serious pediatric infections. Pediatr Infect Dis 1986 0.91
69 Prevention of rheumatic fever: a statement for health professionals by the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease of the Council on Cardiovascular Disease in the young, the American Heart Association. Pediatr Infect Dis J 1989 0.91
70 Complications of mastoiditis with special emphasis on venous sinus thrombosis. J Pediatr 1982 0.90
71 Circulating cardiac troponin I levels in Kawasaki disease. Pediatr Cardiol 2001 0.90
72 Generalized nonsuppurative myositis with staphylococcal septicemia. J Pediatr 1980 0.90
73 Treatment of Salmonella meningitis and brain abscess with the new cephalosporins: two case reports and a review of the literature. Pediatr Infect Dis J 1987 0.89
74 Recent developments and controversies in Kawasaki disease. Minerva Pediatr 2004 0.89
75 A.H.A. committee report. Prevention of rheumatic fever. Circulation 1977 0.89
76 Immunoconglutinin and complement studies in congenital nephrotic syndrome and nephritis of Henoch-Schönlein purpura in children. Arch Dis Child 1971 0.89
77 Pulmonary paragonimiasis in Laotian refugee children. Pediatrics 1982 0.89
78 Serum interferon concentrations and retroviral serology in Kawasaki syndrome. Pediatr Infect Dis J 1988 0.89
79 Myocardial injury in children with respiratory syncytial virus infection. Pediatr Crit Care Med 2000 0.88
80 Treatment of pediatric infections with amikacin as first-line aminoglycoside. Am J Med 1985 0.87
81 Staphylococcal osteomyelitis, sepsis, and pulmonary disease. Observations of 10 patients with combined osseous and pulmonary infections. Radiology 1975 0.87
82 Severe neonatal enteroviral hepatitis treated with pleconaril. Pediatr Infect Dis J 2001 0.87
83 The problem of maternal syphilis after serologic surveillance during pregnancy. Am J Obstet Gynecol 1973 0.86
84 Kawasaki syndrome. Curr Probl Pediatr 1991 0.86
85 Pseudomonas stutzeri: an unusual cause of calcaneal Pseudomonas osteomyelitis. Pediatr Infect Dis J 1987 0.86
86 Lack of influence of beta-lactamase-producing flora on recovery of group A streptococci after treatment of acute pharyngitis. J Pediatr 1990 0.86
87 The changing spectrum of neonatal endocarditis. Clin Perinatol 1988 0.85
88 Prevention of bacterial endocarditis: recommendations by the American Heart Association. J Am Dent Assoc 1997 0.85
89 Bacterial and fungal colonization of endotracheal tubes in children: a prospective study. Crit Care Med 1992 0.84
90 Surface and cytoplasmic immunoglobulin expression in circulating B-lymphocytes in acute Kawasaki disease. Pediatr Res 2001 0.84
91 Mucocutaneous lymph node syndrome (Kawasaki disease): delayed aortic and mitral insufficiency secondary to active valvulitis. J Am Coll Cardiol 1986 0.84
92 The significance of serial measurements of serum complement C3 and C4 components and DNA binding capacity in patients with lupus nephritis. Clin Nephrol 1979 0.84
93 Salmonella cholera-suis: a distinctive bacterial pathogen. J Pediatr 1981 0.83
94 Severe staphylococcal sepsis in adolescents. Pediatrics 1976 0.83
95 Combination antibiotic therapy in pediatrics. Am J Med 1986 0.83
96 Are the Duke criteria superior to the Beth Israel criteria for the diagnosis of infective endocarditis in children? Clin Infect Dis 1998 0.83
97 The rise and fall (and rise?) of rheumatic fever. JAMA 1988 0.83
98 Plasmids of Ewingella americana: supplementary epidemiologic markers in an outbreak of pseudobacteremia. J Clin Microbiol 1987 0.82
99 High-dose aspirin in Kawasaki disease. J Pediatr 1999 0.82
100 Coronary artery bypass grafting for Kawasaki disease. Pediatr Cardiol 2002 0.82
101 Qualitative and quantitative aspects of the human antibody response to streptococcal group A carbohydrate. J Clin Invest 1974 0.82
102 Efficacy of ceftriaxone in treatment of serious childhood infections. J Pediatr 1983 0.82
103 Uveitis complicating autoimmune chronic active hepatitis. Am J Dis Child 1983 0.81
104 Group C and group G streptococci. In-office isolation from children and adolescents with pharyngitis. Clin Pediatr (Phila) 1986 0.81
105 Usefulness of echocardiographic evidence of pericardial effusion and mitral regurgitation during the acute stage in predicting development of coronary arterial aneurysms in the late stage of Kawasaki disease. Am J Cardiol 1987 0.80
106 What is the status of intravenous gamma-globulin for Kawasaki syndrome in the United States and Canada? Pediatr Infect Dis J 1988 0.80
107 Comparative safety and efficacy of two immune globulin products in Kawasaki disease. J Pediatr 1995 0.80
108 Current therapy for acute Kawasaki syndrome. J Pediatr 1991 0.79
109 Ceftriaxone therapy of group B streptococcal bacteraemia and meningitis in infant rats. J Antimicrob Chemother 1983 0.79
110 Failure of a single dose of ceftriaxone to eradicate nasopharyngeal colonization of Haemophilus influenzae type b. J Pediatr 1987 0.79
111 In vitro correlates of the L. casei animal model of Kawasaki disease. J Rheumatol 1993 0.78
112 Feasibility of exercise stress echocardiography for the follow-up of children with coronary involvement secondary to Kawasaki disease. Circulation 1995 0.78
113 Eikenella corrodens osteomyelitis. Pediatrics 1982 0.78
114 Prepubertal oral pemphigus vulgaris. J Am Dent Assoc 1980 0.78
115 Moxalactam in the treatment of pediatric infections. Am J Dis Child 1982 0.78
116 A double-blind evaluation of transfer factor therapy of HBsAg-positive chronic aggressive hepatitis: preliminary report of efficacy. Cell Immunol 1979 0.78
117 Characterization and antibody-binding capacity of streptococcal group A carbohydrate haptens. J Immunol 1973 0.78
118 Acyclovir treatment of disseminated varicella in childhood malignant neoplasms. Am J Dis Child 1985 0.78
119 Cryoprecipitates in Kawasaki syndrome: association with coronary artery aneurysms. Pediatr Infect Dis J 1988 0.78
120 CD84 is markedly up-regulated in Kawasaki disease arteriopathy. Clin Exp Immunol 2014 0.78
121 Critical evaluation of a CLIA-waived streptococcal antigen detection test in the emergency department. Ann Emerg Med 2001 0.77
122 Diagnosis and management of children with Kawasaki disease. Heart Dis Stroke 1994 0.76
123 Anti-nuclear antibodies in Sydenham's chorea. Adv Exp Med Biol 1997 0.75
124 Association of toxic shock syndrome toxin-secreting and exfoliative toxin-secreting Staphylococcus aureus with Kawasaki syndrome complicated by coronary artery disease. Pediatr Res 1998 0.75
125 Hepatic abscess and Peptococcus bacteremia. Pediatr Infect Dis J 1989 0.75
126 Hemolysis in Kawasaki disease. Transfusion 1991 0.75
127 Streptococcus viridans--not! Am J Dis Child 1993 0.75
128 In vitro activity of antibiotics alone and in combination against Actinobacillus actinomycetemcomitans. Antimicrob Agents Chemother 1986 0.75
129 Rifampin and penicillin for the elimination of group B streptococci in nasally colonized infant rats. Pediatr Res 1985 0.75
130 Treatment of Kawasaki disease with corticosteroid. J Pediatr 1996 0.75
131 Human coronavirus-NL63 infection is not associated with acute Kawasaki disease. Adv Exp Med Biol 2006 0.75
132 Cholangitis complicating congenital hepatic fibrosis. Am J Dig Dis 1975 0.75
133 The control of rheumatic fever. Clin Pediatr (Phila) 1975 0.75
134 Acute measles complicated by fatal adenovirus pneumonia with bone marrow failure: lack of evidence for direct viral invasion of the bone marrow. Pediatr Infect Dis J 1992 0.75
135 Coronary arteriovenous fistulae mimicking cardiovascular sequelae of Kawasaki disease. Pediatr Cardiol 1993 0.75
136 New perspectives in the drug treatment of Kawasaki disease. Paediatr Drugs 2000 0.75
137 Prevention of bacterial endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Bacterial Endocarditis of the Council on Cardiovascular Diseases in the Young of the American Heart Association. Am J Dis Child 1985 0.75
138 Acute myocarditis associated with Shigella sonnei gastroenteritis. J Pediatr 1993 0.75
139 Prevention of rheumatic fever. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Disease in the Young. Circulation 1984 0.75
140 The significance of the left atrial appendage in rheumatic heart disease. Circulation 1976 0.75
141 Systemic lupus erythematosus glomerulonephritis in children. Paediatrician 1981 0.75
142 Fat embolism in childhood. Review with report of a fatal case related to physical therapy in a child with dermatomyositis. Am J Dis Child 1970 0.75
143 Hematogenous pelvic osteomyelitis in children. Clinical correlates of newer scanning methods. Am J Dis Child 1985 0.75
144 Prevention of bacterial endocarditis. Conn Med 1983 0.75
145 Kawasaki disease: new etiologic clues and advances in therapy. Pediatr Dermatol 1987 0.75
146 Infections in sickle-cell disease. N Engl J Med 1972 0.75
147 Serologic cross-reactions among streptococcal group A, A-variant, and C polysaccharides. Clin Immunol Immunopathol 1983 0.75
148 Congenital complete heart block associated with maternal mixed connective tissue disease. J Pediatr 1979 0.75
149 Measles immunization. J Fla Med Assoc 1979 0.75
150 Radiological case of the month. Congenital syphilis with Parrot's pseudoparalysis. Am J Dis Child 1970 0.75
151 Acute vs. recurrent pharyngitis. Pediatr Infect Dis J 1991 0.75
152 Editorial: Acute rheumatic fever and rheumatic heart disease. J Fla Med Assoc 1976 0.75
153 Probable herpes simplex virus type 1-related acute parotitis, nephritis and erythema multiforme. Pediatr Infect Dis J 1988 0.75
154 Report of the National Institutes of Health Workshop on Kawasaki Disease. J Rheumatol 1999 0.75
155 Advances in antiviral therapy: acyclovir. Pediatr Dermatol 1984 0.75
156 Clinical significance of the presence of cryoglobulins in patients with glomerulopathies not associated with systemic disease. Clin Nephrol 1980 0.75
157 Multiple nosocomial infections: a risk of modern intensive care. Clin Pediatr (Phila) 1980 0.75
158 Subacute bacterial endocarditis in Florida. J Fla Med Assoc 1978 0.75
159 Incomplete Kawasaki disease with coronary artery involvement. Prog Clin Biol Res 1987 0.75
160 Group A streptococcal carrier state. Am J Dis Child 1988 0.75
161 Immune complexes in Kawasaki syndrome: a review. Prog Clin Biol Res 1987 0.75
162 The first reported case of Kawasaki disease? J Pediatr 1999 0.75
163 Streptococcal pharyngitis. What's new. Postgrad Med 1988 0.75
164 Clinical trials of transfer factors. N Engl J Med 1980 0.75
165 The decline of rheumatic fever. What impact on our management of pharyngitis? Am J Dis Child 1984 0.75
166 Albendazole treatment of recurrent echinococcosis. Pediatr Infect Dis J 1988 0.75
167 Peritonitis as a late manifestations of Group B streptococcal disease in newborns. Pediatr Infect Dis 1983 0.75
168 Antibiotics and pharyngitis. Pediatr Infect Dis 1984 0.75
169 What is a throat culture? Adv Exp Med Biol 1997 0.75
170 Multiple recurrent gram-negative cerebrospinal fluid shunt infections associated with a patient with a retained ventricular foreign body. Pediatr Neurosurg 1999 0.75
171 Congenital mucocutaneous candidiasis following diagnostic amniocentesis. Am J Obstet Gynecol 1983 0.75
172 Recurrent hydatid disease after therapy with albendazole. Pediatr Infect Dis J 1993 0.75
173 Letter: Transfer factor in treating hepatitis B (cont.). N Engl J Med 1976 0.75
174 Antigen detection test for group A beta-hemolytic streptococcal pharyngitis that is sufficiently sensitive for use without confirmatory cultures. Adv Exp Med Biol 1997 0.75
175 Campylobacter infection. Pediatrics 1983 0.75
176 Abdominal pain in acute rheumatic fever. An unusual demonstration of the mimetic nature of this disease. Clin Pediatr (Phila) 1971 0.75
177 Kawasaki syndrome. Adv Pediatr 1991 0.75
178 Group C streptococcal endocarditis. Pediatrics 1985 0.75
179 The clinical efficacy of IVGG in Kawasaki disease. Clin Rev Allergy 1992 0.75
180 [Kawasaki disease]. Bol Med Hosp Infant Mex 1991 0.75
181 Prevention of bacterial endocarditis. Recommendations by the American Heart Association. GMDA Bull 1991 0.75
182 Poststreptococcal arthritis. Pediatr Infect Dis J 1988 0.75
183 Management of Kawasaki disease. J Pediatr 1988 0.75